These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 216848

  • 21. Inhibition of cowpox virus infection in mice by interferon therapy.
    Sypulowa A, Zielińska-Jenczylik J, Skurska Z.
    Arch Immunol Ther Exp (Warsz); 1972; 20(6):837-40. PubMed ID: 4664108
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Clinical testing of human interferon in infectious diseases.
    Merigan TC.
    In Vitro Monogr; 1974; (3):57-62. PubMed ID: 4377883
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Modern Russian Etiotropic Antiinfluenza Drugs].
    Ershov FI, Poloskov VV.
    Antibiot Khimioter; 2014; 59(11-12):40-4. PubMed ID: 26448993
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Prospects in the use of the interferon system in the prevention and treatment of viral infections].
    Dianzani F, Viano I, Zucca M.
    G Ital Chemioter; 1974; 21(2):67-78. PubMed ID: 4471329
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Selective use of antiviral inhibitors: interferon, its inducers, and blockade of viral-reverse transcriptase.
    Carter WA, O'Malley JA, Horoszewicz JS, Huang J.
    Transplant Proc; 1975 Jun; 7(2):269-73. PubMed ID: 236611
    [No Abstract] [Full Text] [Related]

  • 38. [Metabolic substances produced by animal cells--interferon].
    Kishida T, Oku T.
    Yakugaku Zasshi; 1983 May; 103(5):483-96. PubMed ID: 6196476
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP.
    Virology; 1999 May 10; 257(2):363-72. PubMed ID: 10329547
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.